When did UroGen Pharma report Q4 2024 earnings?

UroGen Pharma (URGN) reported Q4 2024 earnings on March 10, 2025 before market open.

What were UroGen Pharma's Q4 2024 revenue and EPS?

UroGen Pharma reported revenue of $24.6M and eps of $-0.80 for Q4 2024.

Did UroGen Pharma beat estimates in Q4 2024?

Revenue beat the consensus estimate of $23.3M by $1.2M. EPS missed the consensus estimate of $-0.69 by $0.11.

Where can I find UroGen Pharma's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001437749-25-006842) directly on SEC EDGAR. The filing index links above go to sec.gov.

UroGen Pharma URGN Q4 2024 Annual earnings

Reported March 10, 2025 · Before market open

Revenue$24.6MBeat by $1.2M

EPS-$0.80Miss by $0.11

Revenue estimate$23.3M

EPS estimate-$0.69

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$63.5M

EPS estimate-$0.27

Financials

Q4 2024

Income statement

See full

Revenue$24.6M+4.4%

Net income-$37.5M-44.2%

Balance sheet

See full

Cash & equivalents$172.0M+81.0%

Total debt$125.5M+24.2%

Total equity-$8.8M+86.5%

Total assets$285.7M+60.2%

Cash flow

See full

Operating cash flow-$13.6M-4.8%

CapEx$115.0K+105%

Free cash flow-$13.7M-5.2%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$449.42M-17.1%

Enterprise value$402.93M-26.5%

P/S5×-1.6×

Profitability

See full

Net margin-140.4%+22.0pp

FCF margin-107.4%+20.4pp

Returns & leverage

See full

Current ratio6×+0.6×

Versus estimates

Revenue

Q1 2026$51.0MBeat by $6.1M Q4 2025$37.8MMiss by $2.1M Q3 2025$27.5MMiss by $12.7M Q2 2025$24.2MMiss by $9.4M Q1 2025$20.3MMiss by $3.0M

Q4 2024$24.6MBeat by $1.2M

Diluted EPS

Q1 2026-$0.47Beat by $0.09 Q4 2025-$0.54Miss by $0.02 Q3 2025-$0.69Beat by $0.03 Q2 2025-$1.05Miss by $0.23 Q1 2025-$0.92Miss by $0.09

Q4 2024-$0.80Miss by $0.11

Ask the moment UroGen Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did UroGen Pharma report Q4 2024 earnings?: UroGen Pharma (URGN) reported Q4 2024 earnings on March 10, 2025 before market open.
What were UroGen Pharma's Q4 2024 revenue and EPS?: UroGen Pharma reported revenue of $24.6M and eps of $-0.80 for Q4 2024.
Did UroGen Pharma beat estimates in Q4 2024?: Revenue beat the consensus estimate of $23.3M by $1.2M. EPS missed the consensus estimate of $-0.69 by $0.11.
Where can I find UroGen Pharma's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001437749-25-006842) directly on SEC EDGAR. The filing index links above go to sec.gov.